These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33865336)

  • 21. Histogram Analysis of Perfusion Parameters from Dynamic Contrast-Enhanced MR Imaging with Tumor Characteristics and Therapeutic Response in Locally Advanced Rectal Cancer.
    Yeo DM; Oh SN; Choi MH; Lee SH; Lee MA; Jung SE
    Biomed Res Int; 2018; 2018():3724393. PubMed ID: 30186857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histogram analysis parameters of dynamic contrast-enhanced magnetic resonance imaging can predict histopathological findings including proliferation potential, cellularity, and nucleic areas in head and neck squamous cell carcinoma.
    Surov A; Meyer HJ; Leifels L; Höhn AK; Richter C; Winter K
    Oncotarget; 2018 Apr; 9(30):21070-21077. PubMed ID: 29765520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-tumor histogram analysis of multi-parametric MRI for differentiating brain metastases histological subtypes in lung cancers: relationship with the Ki-67 proliferation index.
    Zhang B; Zhou F; Zhou Q; Xue C; Ke X; Zhang P; Han T; Deng L; Jing M; Zhou J
    Neurosurg Rev; 2023 Sep; 46(1):218. PubMed ID: 37659040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.
    Xu L; Ge X; Sun N; Liu X
    Acta Radiol; 2020 Oct; 61(10):1316-1325. PubMed ID: 32053003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative perfusion histogram parameters of dynamic contrast-enhanced MRI to identify different pathological types of uterine leiomyoma.
    Wang S; Zhao Z; Zhang Y; Yang L; Huang Y; Ruan Y; Wang C
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Feb; 50(1):97-105. PubMed ID: 34117849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic contrast-enhanced magnetic resonance imaging in cervical cancer: correlation between quantitative parameters and molecular markers hypoxia-inducible factors-1-alpha, vascular endothelial growth factor, and Ki-67.
    Liu B; Gao H; Zhou F; Zhao W; Yang Y
    Clin Radiol; 2024 Jun; 79(6):e826-e833. PubMed ID: 38582634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of dynamic contrast-enhanced MR imaging features and influence factors of pelvic bone marrow in adult females.
    Zhang X; Pang H; Dong Y; Shi D; Liu F; Luo Y; Yu T; Wang X
    Osteoporos Int; 2019 Dec; 30(12):2469-2476. PubMed ID: 31451839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations Between Histogram Analysis DCE MRI Parameters and Complex
    Surov A; Leifels L; Meyer HJ; Winter K; Sabri O; Purz S
    Anticancer Res; 2018 Mar; 38(3):1637-1642. PubMed ID: 29491096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microvessel barrier dysfunction in sinonasal inverted papilloma-associated squamous cell carcinoma and its manifestation in dynamic contrast-enhanced MRI.
    Xian M; Yu J; Li Z; Piao Y; Wang C; Xian J; Zhang L
    Int Forum Allergy Rhinol; 2024 Jul; 14(7):1173-1181. PubMed ID: 38247185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
    Kang SR; Kim HW; Kim HS
    J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical characterization of the mTOR pathway in stage-I non-small-cell lung carcinoma.
    Shin E; Choi CM; Kim HR; Jang SJ; Park YS
    Lung Cancer; 2015 Jul; 89(1):13-8. PubMed ID: 25936472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
    Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
    Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma.
    Stojsic J; Stankovic T; Stojkovic S; Milinkovic V; Dinic J; Milosevic Z; Milovanovic Z; Tanic N; Bankovic J
    Exp Mol Pathol; 2015 Feb; 98(1):27-32. PubMed ID: 25449334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histogram Analysis Comparison of Monoexponential, Advanced Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI for Differentiating Borderline From Malignant Epithelial Ovarian Tumors.
    He M; Song Y; Li H; Lu J; Li Y; Duan S; Qiang J
    J Magn Reson Imaging; 2020 Jul; 52(1):257-268. PubMed ID: 31922327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting T and N Staging of Resectable Gastric Cancer According to Whole Tumor Histogram Analysis About a Non-Cartesian k-Space Acquisition DCE-MRI: A Feasibility Study.
    Yan L; Qu J; Li J; Zhang H; Lu Y; Gao J
    Cancer Manag Res; 2021; 13():7951-7960. PubMed ID: 34703316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
    Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
    Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Papillomavirus and Epidermal Growth Factor Receptor in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma: Correlation With Dynamic Contrast-Enhanced MRI Parameters.
    Choi YS; Park M; Kwon HJ; Koh YW; Lee SK; Kim J
    AJR Am J Roentgenol; 2016 Feb; 206(2):408-13. PubMed ID: 26797372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paired genomic analysis of squamous cell carcinoma transformed from EGFR-mutated lung adenocarcinoma.
    Park S; Shim JH; Lee B; Cho I; Park WY; Kim Y; Lee SH; Choi Y; Han J; Ahn JS; Ahn MJ; Park K; Sun JM
    Lung Cancer; 2019 Aug; 134():7-15. PubMed ID: 31319998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberous-sclerosis complex-related cell signaling in the pathogenesis of lung cancer.
    Fuchs A; König K; Heukamp LC; Fassunke J; Kirfel J; Huss S; Becker AJ; Büttner R; Majores M
    Diagn Pathol; 2014 Mar; 9():48. PubMed ID: 24593867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.